Allurion Technologies
Agent38Agent Readiness: 38/100. Below median. Measured by StartupHub.ai. Median 41.A medical device company offering a comprehensive, swallowable gastric balloon program for weight loss.
About
Allurion Technologies is a medical device company dedicated to ending obesity through its innovative Allurion Program. This program features the Elipse Balloon, the world's first and only swallowable, procedure-less gastric balloon for weight loss, combined with a connected scale, smartwatch, mobile app, and personalized clinical support. The program aims to provide a holistic and accessible solution for individuals seeking to manage their weight.
Key facts
At-a-glance profile data
- Website
- allurion.com
- Headquarters
- Natick, Massachusetts, United States
- Founded
- 2009
- Employees
- 142
- Total funding
- $172M (Private Placement)
- Business model
- B2B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Nov 2025 | Private Placement | $5M | - |
| 24 Jan 2025 | Registered Direct Offering | $7M | - |
| 26 Jun 2024 | Public Offering | $20M | Jefferies Financial Group Inc., Cowen |
| 1 Aug 2023 | IPO | $100M | - |
| 7 Jan 2020 | Growth Capital | $34M | - |
| 1 Oct 2017 | Venture Funding | $6M | - |
Tech stack
Detected on allurion.com, last scanned 22 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- Support
- HubSpot
- Hosting
- AWS
- Email provider
- Mimecast
Frequently asked
How much funding has Allurion Technologies raised?
Allurion Technologies has raised a total of $172M in funding. The most recent round on record is Private Placement.
How many employees does Allurion Technologies have?
Allurion Technologies has approximately 142 people on record.